| 영문 | doctor-patient relationship | 한글 | 의사환자관계 |
|---|---|---|---|
| 설명 | 사회적으로 기대되는 각 역할에 따른 상호행위를 통해서 의사와 환자가 맺는 관계. 의사-환자관계는, ① 능동적-수동적관계, ② 지도-협력관계, ③ 상호참가관계의 세 가지로 유형화할 수 있다. 질병구조의 중심이 급성 질환에서 만성질환으로 이행하는 가운데 의사-환자관계도 ①에서 ③으로 바뀌는 것이 요구되고 있다. 그러나 일방적으로 일하는 의사와 지시에 따르기만 하는 수동적 환자와의 관계는 아직도 뿌리깊게 남아있다. 또 최근의 의료기계화는 의사와 환자가 기계를 매개로 해서 간접적으로 상호연관되는 새로운 관계까지도 낳고 있다. |
||
| HCG, hCG | Human Chorionic Gonadotropin; 사람융모성성선자극호르몬 1. Placental Glycoprotein Hormone &nbs... |
|---|---|
| ICU | infant care unit; immunologic contact urticaria; intensive care unit; intermediate care unit |
| OILD | occupational immunologic lung disease |
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
| DPFR | diastolic pressure-flow relationship |
| CCRT | Core Conflictual Relationship Theme |
|---|---|
| ESPVR | End-systolic pressure-volume relationship |
| LSER | Linear Solvation Energy Relationship |
| LFER | linear free energy relationship |
| QSAR | Quantitative Structure Activity Relationship |
| dose-response relationship, immunologic | A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. (12 Dec 1998) |
|---|
| blood relationship | A relationship that share a common bloodline, descent from a common ancestor. (27 Sep 1997) |
|---|---|
| relationship | The state of being related, associated, or connected. (05 Mar 2000) |
| coefficient of relationship | The probability that a gene present in one mate is also present in the other and is derived from the same source. (05 Mar 2000) |
| Haldane relationship | <biochemistry> A mathematical relationship between the equilibrium constant of an enzyme-catalyzed reaction and all of that enzyme's kinetic parameters (e.g., Vmax and Km's). (05 Mar 2000) |
| sadomasochistic relationship | A relationship characterised by the complementary enjoyment of inflicting and suffering cruelty. (05 Mar 2000) |
| hypnotic relationship | Relationship between hypnotiser, or hypnotist, and the hypnotised, or hypnotee. (05 Mar 2000) |
| structure-activity relationship | The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects. (12 Dec 1998) |
| dose-response relationship | Relationship in which a change in the amount, intensity, or duration of exposure is associated with a change in risk of a specified outcome. (05 Mar 2000) |
| dose-response relationship, drug | The relationship between the dose of an administered drug and the response of the organism to the drug. (12 Dec 1998) |
| dose-response relationship, radiation | The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. (12 Dec 1998) |
| object relationship | In the behavioural sciences, the emotional bond between an individual and another person (or between two groups), as opposed to the individual's (or group's) interest in him or herself (itself). (05 Mar 2000) |
| adjuvants, immunologic | Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (freund's adjuvant, bcg, corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (12 Dec 1998) |
| receptors, immunologic | Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behaviour of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. (12 Dec 1998) |
| graft enhancement, immunologic | The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. (12 Dec 1998) |
| monitoring, immunologic | Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumour antigen and other markers (often by radioimmunoassay), studies of cellular or humoral immunity in cancer aetiology, immunotherapy trials, etc. (12 Dec 1998) |
Synonyms : Immunologic Dose-Response Relationship, Relationship, Immunologic Dose-Response, Dose Response Relationship, Immunologic, Dose-Response Relationships, Immunologic, Immunologic Dose Response Relationship, Immunologic Dose-Response Relationships
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|